nodes	percent_of_prediction	percent_of_DWPC	metapath
Mitoxantrone—CYP1B1—esophageal cancer	0.426	0.777	CbGaD
Mitoxantrone—ABCB1—esophageal cancer	0.122	0.223	CbGaD
Mitoxantrone—ABCG2—Carboplatin—esophageal cancer	0.0567	0.267	CbGbCtD
Mitoxantrone—ABCG2—Cisplatin—esophageal cancer	0.0484	0.228	CbGbCtD
Mitoxantrone—ABCC1—Methotrexate—esophageal cancer	0.047	0.221	CbGbCtD
Mitoxantrone—ABCG2—Methotrexate—esophageal cancer	0.0314	0.148	CbGbCtD
Mitoxantrone—ABCB1—Cisplatin—esophageal cancer	0.0175	0.0822	CbGbCtD
Mitoxantrone—ABCB1—Methotrexate—esophageal cancer	0.0113	0.0534	CbGbCtD
Mitoxantrone—SLC47A2—digestive system—esophageal cancer	0.00229	0.0902	CbGeAlD
Mitoxantrone—BTK—bronchus—esophageal cancer	0.00223	0.088	CbGeAlD
Mitoxantrone—PIM1—bronchus—esophageal cancer	0.00193	0.0762	CbGeAlD
Mitoxantrone—PIM1—trachea—esophageal cancer	0.00174	0.0685	CbGeAlD
Mitoxantrone—PIM1—digestive system—esophageal cancer	0.00149	0.0589	CbGeAlD
Mitoxantrone—BTK—lung—esophageal cancer	0.00144	0.0568	CbGeAlD
Mitoxantrone—PIM1—lung—esophageal cancer	0.00125	0.0492	CbGeAlD
Mitoxantrone—TOP2A—bronchus—esophageal cancer	0.00113	0.0447	CbGeAlD
Mitoxantrone—Febrile neutropenia—Cisplatin—esophageal cancer	0.00108	0.0103	CcSEcCtD
Mitoxantrone—Serum creatinine increased—Cisplatin—esophageal cancer	0.00105	0.0101	CcSEcCtD
Mitoxantrone—Enteritis—Methotrexate—esophageal cancer	0.00104	0.00999	CcSEcCtD
Mitoxantrone—BTK—lymph node—esophageal cancer	0.000984	0.0388	CbGeAlD
Mitoxantrone—Cardiomyopathy—Capecitabine—esophageal cancer	0.000933	0.00896	CcSEcCtD
Mitoxantrone—Sudden death—Capecitabine—esophageal cancer	0.000933	0.00896	CcSEcCtD
Mitoxantrone—Mucosal inflammation—Capecitabine—esophageal cancer	0.000863	0.00828	CcSEcCtD
Mitoxantrone—PIM1—lymph node—esophageal cancer	0.000853	0.0336	CbGeAlD
Mitoxantrone—Necrosis—Cisplatin—esophageal cancer	0.000826	0.00793	CcSEcCtD
Mitoxantrone—Platelet count decreased—Capecitabine—esophageal cancer	0.000803	0.00771	CcSEcCtD
Mitoxantrone—SLC47A1—digestive system—esophageal cancer	0.0008	0.0316	CbGeAlD
Mitoxantrone—Febrile neutropenia—Capecitabine—esophageal cancer	0.000794	0.00762	CcSEcCtD
Mitoxantrone—Infection—Carboplatin—esophageal cancer	0.000783	0.00752	CcSEcCtD
Mitoxantrone—Serum creatinine increased—Capecitabine—esophageal cancer	0.000777	0.00746	CcSEcCtD
Mitoxantrone—Extravasation—Cisplatin—esophageal cancer	0.000743	0.00713	CcSEcCtD
Mitoxantrone—CYP1B1—smooth muscle tissue—esophageal cancer	0.000743	0.0293	CbGeAlD
Mitoxantrone—Interstitial pneumonia—Methotrexate—esophageal cancer	0.000736	0.00707	CcSEcCtD
Mitoxantrone—TOP2A—lung—esophageal cancer	0.000731	0.0289	CbGeAlD
Mitoxantrone—Bone marrow depression—Capecitabine—esophageal cancer	0.000708	0.00679	CcSEcCtD
Mitoxantrone—Hyperuricaemia—Cisplatin—esophageal cancer	0.000699	0.00671	CcSEcCtD
Mitoxantrone—Sudden death—Methotrexate—esophageal cancer	0.000695	0.00667	CcSEcCtD
Mitoxantrone—Haemoglobin decreased—Capecitabine—esophageal cancer	0.000694	0.00666	CcSEcCtD
Mitoxantrone—Ulcer—Cisplatin—esophageal cancer	0.000685	0.00658	CcSEcCtD
Mitoxantrone—ABCC1—bronchus—esophageal cancer	0.000683	0.0269	CbGeAlD
Mitoxantrone—Pain—Carboplatin—esophageal cancer	0.000674	0.00647	CcSEcCtD
Mitoxantrone—SLC47A1—lung—esophageal cancer	0.000668	0.0264	CbGeAlD
Mitoxantrone—Blood uric acid increased—Cisplatin—esophageal cancer	0.00066	0.00634	CcSEcCtD
Mitoxantrone—Mucosal inflammation—Methotrexate—esophageal cancer	0.000642	0.00617	CcSEcCtD
Mitoxantrone—Hyperkalaemia—Cisplatin—esophageal cancer	0.000637	0.00611	CcSEcCtD
Mitoxantrone—Body temperature increased—Carboplatin—esophageal cancer	0.000623	0.00598	CcSEcCtD
Mitoxantrone—Fungal infection—Capecitabine—esophageal cancer	0.000619	0.00594	CcSEcCtD
Mitoxantrone—ABCC1—trachea—esophageal cancer	0.000613	0.0242	CbGeAlD
Mitoxantrone—Myocardial ischaemia—Capecitabine—esophageal cancer	0.000594	0.00571	CcSEcCtD
Mitoxantrone—Febrile neutropenia—Methotrexate—esophageal cancer	0.000591	0.00568	CcSEcCtD
Mitoxantrone—CYP1B1—digestive system—esophageal cancer	0.000586	0.0231	CbGeAlD
Mitoxantrone—Petechiae—Capecitabine—esophageal cancer	0.000581	0.00558	CcSEcCtD
Mitoxantrone—Contusion—Capecitabine—esophageal cancer	0.000547	0.00526	CcSEcCtD
Mitoxantrone—Phlebitis—Cisplatin—esophageal cancer	0.000546	0.00524	CcSEcCtD
Mitoxantrone—Proteinuria—Capecitabine—esophageal cancer	0.000544	0.00522	CcSEcCtD
Mitoxantrone—Protein urine present—Capecitabine—esophageal cancer	0.000536	0.00515	CcSEcCtD
Mitoxantrone—Bone marrow depression—Methotrexate—esophageal cancer	0.000527	0.00506	CcSEcCtD
Mitoxantrone—Hypocalcaemia—Capecitabine—esophageal cancer	0.000522	0.00501	CcSEcCtD
Mitoxantrone—Cardiac failure congestive—Cisplatin—esophageal cancer	0.000519	0.00498	CcSEcCtD
Mitoxantrone—Renal failure acute—Cisplatin—esophageal cancer	0.000509	0.00489	CcSEcCtD
Mitoxantrone—Blood bilirubin increased—Capecitabine—esophageal cancer	0.000505	0.00485	CcSEcCtD
Mitoxantrone—Ulcer—Capecitabine—esophageal cancer	0.000505	0.00485	CcSEcCtD
Mitoxantrone—Interstitial lung disease—Methotrexate—esophageal cancer	0.000502	0.00482	CcSEcCtD
Mitoxantrone—TOP2A—lymph node—esophageal cancer	0.0005	0.0197	CbGeAlD
Mitoxantrone—Bone pain—Capecitabine—esophageal cancer	0.000499	0.00479	CcSEcCtD
Mitoxantrone—CYP1B1—lung—esophageal cancer	0.00049	0.0193	CbGeAlD
Mitoxantrone—Anaphylactoid reaction—Cisplatin—esophageal cancer	0.000486	0.00467	CcSEcCtD
Mitoxantrone—Hyponatraemia—Cisplatin—esophageal cancer	0.000472	0.00454	CcSEcCtD
Mitoxantrone—Gastrointestinal haemorrhage—Cisplatin—esophageal cancer	0.00047	0.00452	CcSEcCtD
Mitoxantrone—Fungal infection—Methotrexate—esophageal cancer	0.000461	0.00442	CcSEcCtD
Mitoxantrone—SLC47A1—lymph node—esophageal cancer	0.000457	0.018	CbGeAlD
Mitoxantrone—Necrosis—Methotrexate—esophageal cancer	0.000453	0.00435	CcSEcCtD
Mitoxantrone—Blood creatinine increased—Cisplatin—esophageal cancer	0.000441	0.00423	CcSEcCtD
Mitoxantrone—ABCC1—lung—esophageal cancer	0.00044	0.0174	CbGeAlD
Mitoxantrone—Dehydration—Cisplatin—esophageal cancer	0.000437	0.0042	CcSEcCtD
Mitoxantrone—Petechiae—Methotrexate—esophageal cancer	0.000432	0.00415	CcSEcCtD
Mitoxantrone—Ecchymosis—Capecitabine—esophageal cancer	0.000432	0.00415	CcSEcCtD
Mitoxantrone—Hypokalaemia—Cisplatin—esophageal cancer	0.000428	0.00411	CcSEcCtD
Mitoxantrone—Aspartate aminotransferase increased—Cisplatin—esophageal cancer	0.000424	0.00407	CcSEcCtD
Mitoxantrone—Sepsis—Capecitabine—esophageal cancer	0.000415	0.00398	CcSEcCtD
Mitoxantrone—Extravasation—Methotrexate—esophageal cancer	0.000408	0.00391	CcSEcCtD
Mitoxantrone—Proteinuria—Methotrexate—esophageal cancer	0.000405	0.00389	CcSEcCtD
Mitoxantrone—Phlebitis—Capecitabine—esophageal cancer	0.000402	0.00386	CcSEcCtD
Mitoxantrone—Protein urine present—Methotrexate—esophageal cancer	0.000399	0.00383	CcSEcCtD
Mitoxantrone—Sweating increased—Cisplatin—esophageal cancer	0.000396	0.0038	CcSEcCtD
Mitoxantrone—Swelling—Capecitabine—esophageal cancer	0.000393	0.00377	CcSEcCtD
Mitoxantrone—Pancytopenia—Cisplatin—esophageal cancer	0.000386	0.00371	CcSEcCtD
Mitoxantrone—Hyperuricaemia—Methotrexate—esophageal cancer	0.000383	0.00368	CcSEcCtD
Mitoxantrone—CYP2E1—digestive system—esophageal cancer	0.000378	0.0149	CbGeAlD
Mitoxantrone—Hepatic enzyme increased—Methotrexate—esophageal cancer	0.000376	0.00361	CcSEcCtD
Mitoxantrone—Ulcer—Methotrexate—esophageal cancer	0.000376	0.00361	CcSEcCtD
Mitoxantrone—Renal failure acute—Capecitabine—esophageal cancer	0.000376	0.00361	CcSEcCtD
Mitoxantrone—ABCG2—lung—esophageal cancer	0.000365	0.0144	CbGeAlD
Mitoxantrone—Blood uric acid increased—Methotrexate—esophageal cancer	0.000362	0.00348	CcSEcCtD
Mitoxantrone—Acute coronary syndrome—Cisplatin—esophageal cancer	0.000357	0.00343	CcSEcCtD
Mitoxantrone—Renal failure—Cisplatin—esophageal cancer	0.000356	0.00342	CcSEcCtD
Mitoxantrone—Myocardial infarction—Cisplatin—esophageal cancer	0.000355	0.00341	CcSEcCtD
Mitoxantrone—Cardiac failure—Capecitabine—esophageal cancer	0.000355	0.00341	CcSEcCtD
Mitoxantrone—Stomatitis—Cisplatin—esophageal cancer	0.000353	0.00339	CcSEcCtD
Mitoxantrone—Conjunctivitis—Cisplatin—esophageal cancer	0.000352	0.00338	CcSEcCtD
Mitoxantrone—Hyponatraemia—Capecitabine—esophageal cancer	0.000348	0.00334	CcSEcCtD
Mitoxantrone—Gastrointestinal haemorrhage—Capecitabine—esophageal cancer	0.000347	0.00333	CcSEcCtD
Mitoxantrone—CYP1B1—lymph node—esophageal cancer	0.000335	0.0132	CbGeAlD
Mitoxantrone—Bradycardia—Cisplatin—esophageal cancer	0.000331	0.00318	CcSEcCtD
Mitoxantrone—Blood creatinine increased—Capecitabine—esophageal cancer	0.000325	0.00312	CcSEcCtD
Mitoxantrone—Dehydration—Capecitabine—esophageal cancer	0.000322	0.0031	CcSEcCtD
Mitoxantrone—Ecchymosis—Methotrexate—esophageal cancer	0.000322	0.00309	CcSEcCtD
Mitoxantrone—Abdominal pain upper—Capecitabine—esophageal cancer	0.000317	0.00304	CcSEcCtD
Mitoxantrone—CYP2E1—lung—esophageal cancer	0.000316	0.0125	CbGeAlD
Mitoxantrone—Hypokalaemia—Capecitabine—esophageal cancer	0.000316	0.00303	CcSEcCtD
Mitoxantrone—Aspartate aminotransferase increased—Capecitabine—esophageal cancer	0.000312	0.003	CcSEcCtD
Mitoxantrone—Sepsis—Methotrexate—esophageal cancer	0.000309	0.00296	CcSEcCtD
Mitoxantrone—Alanine aminotransferase increased—Capecitabine—esophageal cancer	0.000306	0.00294	CcSEcCtD
Mitoxantrone—CYP3A4—digestive system—esophageal cancer	0.000304	0.012	CbGeAlD
Mitoxantrone—ABCC1—lymph node—esophageal cancer	0.000301	0.0119	CbGeAlD
Mitoxantrone—Sweating increased—Capecitabine—esophageal cancer	0.000292	0.0028	CcSEcCtD
Mitoxantrone—Arrhythmia—Cisplatin—esophageal cancer	0.000291	0.00279	CcSEcCtD
Mitoxantrone—Alopecia—Cisplatin—esophageal cancer	0.000288	0.00276	CcSEcCtD
Mitoxantrone—Pancytopenia—Capecitabine—esophageal cancer	0.000285	0.00273	CcSEcCtD
Mitoxantrone—Erythema—Cisplatin—esophageal cancer	0.000283	0.00272	CcSEcCtD
Mitoxantrone—ABCB1—epithelium—esophageal cancer	0.000283	0.0112	CbGeAlD
Mitoxantrone—Neutropenia—Capecitabine—esophageal cancer	0.00028	0.00269	CcSEcCtD
Mitoxantrone—Renal failure acute—Methotrexate—esophageal cancer	0.00028	0.00268	CcSEcCtD
Mitoxantrone—Upper respiratory tract infection—Capecitabine—esophageal cancer	0.000279	0.00267	CcSEcCtD
Mitoxantrone—Weight increased—Capecitabine—esophageal cancer	0.000273	0.00262	CcSEcCtD
Mitoxantrone—Weight decreased—Capecitabine—esophageal cancer	0.000271	0.0026	CcSEcCtD
Mitoxantrone—Hyperglycaemia—Capecitabine—esophageal cancer	0.00027	0.0026	CcSEcCtD
Mitoxantrone—Pneumonia—Capecitabine—esophageal cancer	0.000269	0.00258	CcSEcCtD
Mitoxantrone—Vision blurred—Cisplatin—esophageal cancer	0.000267	0.00256	CcSEcCtD
Mitoxantrone—Anaphylactoid reaction—Methotrexate—esophageal cancer	0.000267	0.00256	CcSEcCtD
Mitoxantrone—Acute coronary syndrome—Capecitabine—esophageal cancer	0.000263	0.00253	CcSEcCtD
Mitoxantrone—Ill-defined disorder—Cisplatin—esophageal cancer	0.000263	0.00252	CcSEcCtD
Mitoxantrone—Renal failure—Capecitabine—esophageal cancer	0.000263	0.00252	CcSEcCtD
Mitoxantrone—Myocardial infarction—Capecitabine—esophageal cancer	0.000262	0.00252	CcSEcCtD
Mitoxantrone—Anaemia—Cisplatin—esophageal cancer	0.000262	0.00251	CcSEcCtD
Mitoxantrone—Stomatitis—Capecitabine—esophageal cancer	0.00026	0.0025	CcSEcCtD
Mitoxantrone—Jaundice—Capecitabine—esophageal cancer	0.00026	0.0025	CcSEcCtD
Mitoxantrone—Conjunctivitis—Capecitabine—esophageal cancer	0.00026	0.00249	CcSEcCtD
Mitoxantrone—Urinary tract infection—Capecitabine—esophageal cancer	0.00026	0.00249	CcSEcCtD
Mitoxantrone—Malaise—Cisplatin—esophageal cancer	0.000255	0.00245	CcSEcCtD
Mitoxantrone—Haematuria—Capecitabine—esophageal cancer	0.000255	0.00245	CcSEcCtD
Mitoxantrone—Leukopenia—Cisplatin—esophageal cancer	0.000254	0.00243	CcSEcCtD
Mitoxantrone—ABCB1—trachea—esophageal cancer	0.00025	0.00987	CbGeAlD
Mitoxantrone—ABCG2—lymph node—esophageal cancer	0.000249	0.00984	CbGeAlD
Mitoxantrone—Agranulocytosis—Capecitabine—esophageal cancer	0.000249	0.00239	CcSEcCtD
Mitoxantrone—Convulsion—Cisplatin—esophageal cancer	0.000245	0.00236	CcSEcCtD
Mitoxantrone—Bradycardia—Capecitabine—esophageal cancer	0.000244	0.00234	CcSEcCtD
Mitoxantrone—Myalgia—Cisplatin—esophageal cancer	0.000241	0.00232	CcSEcCtD
Mitoxantrone—Haemoglobin—Capecitabine—esophageal cancer	0.000241	0.00232	CcSEcCtD
Mitoxantrone—Rhinitis—Capecitabine—esophageal cancer	0.00024	0.00231	CcSEcCtD
Mitoxantrone—Anxiety—Cisplatin—esophageal cancer	0.00024	0.00231	CcSEcCtD
Mitoxantrone—Haemorrhage—Capecitabine—esophageal cancer	0.00024	0.0023	CcSEcCtD
Mitoxantrone—Hepatitis—Capecitabine—esophageal cancer	0.00024	0.0023	CcSEcCtD
Mitoxantrone—Discomfort—Cisplatin—esophageal cancer	0.000238	0.00229	CcSEcCtD
Mitoxantrone—Pharyngitis—Capecitabine—esophageal cancer	0.000238	0.00229	CcSEcCtD
Mitoxantrone—Oedema—Cisplatin—esophageal cancer	0.000231	0.00222	CcSEcCtD
Mitoxantrone—Anaphylactic shock—Cisplatin—esophageal cancer	0.000231	0.00222	CcSEcCtD
Mitoxantrone—Infection—Cisplatin—esophageal cancer	0.00023	0.00221	CcSEcCtD
Mitoxantrone—Thrombocytopenia—Cisplatin—esophageal cancer	0.000226	0.00217	CcSEcCtD
Mitoxantrone—Tachycardia—Cisplatin—esophageal cancer	0.000226	0.00217	CcSEcCtD
Mitoxantrone—Skin disorder—Cisplatin—esophageal cancer	0.000225	0.00216	CcSEcCtD
Mitoxantrone—Hyperhidrosis—Cisplatin—esophageal cancer	0.000224	0.00215	CcSEcCtD
Mitoxantrone—Anorexia—Cisplatin—esophageal cancer	0.00022	0.00212	CcSEcCtD
Mitoxantrone—Hypotension—Cisplatin—esophageal cancer	0.000216	0.00207	CcSEcCtD
Mitoxantrone—ABCB1—digestive system—esophageal cancer	0.000215	0.00849	CbGeAlD
Mitoxantrone—Chills—Capecitabine—esophageal cancer	0.000215	0.00207	CcSEcCtD
Mitoxantrone—Arrhythmia—Capecitabine—esophageal cancer	0.000214	0.00206	CcSEcCtD
Mitoxantrone—Alopecia—Capecitabine—esophageal cancer	0.000212	0.00204	CcSEcCtD
Mitoxantrone—Pancytopenia—Methotrexate—esophageal cancer	0.000212	0.00203	CcSEcCtD
Mitoxantrone—Musculoskeletal discomfort—Cisplatin—esophageal cancer	0.000211	0.00202	CcSEcCtD
Mitoxantrone—Erythema—Capecitabine—esophageal cancer	0.000209	0.00201	CcSEcCtD
Mitoxantrone—Neutropenia—Methotrexate—esophageal cancer	0.000209	0.002	CcSEcCtD
Mitoxantrone—Paraesthesia—Cisplatin—esophageal cancer	0.000208	0.00199	CcSEcCtD
Mitoxantrone—Upper respiratory tract infection—Methotrexate—esophageal cancer	0.000207	0.00199	CcSEcCtD
Mitoxantrone—Dyspnoea—Cisplatin—esophageal cancer	0.000206	0.00198	CcSEcCtD
Mitoxantrone—Erectile dysfunction—Methotrexate—esophageal cancer	0.000205	0.00197	CcSEcCtD
Mitoxantrone—Dysgeusia—Capecitabine—esophageal cancer	0.000204	0.00196	CcSEcCtD
Mitoxantrone—Back pain—Capecitabine—esophageal cancer	0.000202	0.00194	CcSEcCtD
Mitoxantrone—Decreased appetite—Cisplatin—esophageal cancer	0.000201	0.00193	CcSEcCtD
Mitoxantrone—Pneumonia—Methotrexate—esophageal cancer	0.0002	0.00192	CcSEcCtD
Mitoxantrone—Drowsiness—Methotrexate—esophageal cancer	0.000199	0.00191	CcSEcCtD
Mitoxantrone—Pain—Cisplatin—esophageal cancer	0.000198	0.0019	CcSEcCtD
Mitoxantrone—Vision blurred—Capecitabine—esophageal cancer	0.000197	0.00189	CcSEcCtD
Mitoxantrone—Renal failure—Methotrexate—esophageal cancer	0.000196	0.00188	CcSEcCtD
Mitoxantrone—Stomatitis—Methotrexate—esophageal cancer	0.000194	0.00186	CcSEcCtD
Mitoxantrone—Ill-defined disorder—Capecitabine—esophageal cancer	0.000194	0.00186	CcSEcCtD
Mitoxantrone—Conjunctivitis—Methotrexate—esophageal cancer	0.000193	0.00186	CcSEcCtD
Mitoxantrone—Anaemia—Capecitabine—esophageal cancer	0.000193	0.00185	CcSEcCtD
Mitoxantrone—Sweating—Methotrexate—esophageal cancer	0.000191	0.00183	CcSEcCtD
Mitoxantrone—Feeling abnormal—Cisplatin—esophageal cancer	0.000191	0.00183	CcSEcCtD
Mitoxantrone—Haematuria—Methotrexate—esophageal cancer	0.00019	0.00182	CcSEcCtD
Mitoxantrone—Malaise—Capecitabine—esophageal cancer	0.000188	0.00181	CcSEcCtD
Mitoxantrone—Leukopenia—Capecitabine—esophageal cancer	0.000187	0.00179	CcSEcCtD
Mitoxantrone—Agranulocytosis—Methotrexate—esophageal cancer	0.000186	0.00178	CcSEcCtD
Mitoxantrone—Body temperature increased—Cisplatin—esophageal cancer	0.000183	0.00175	CcSEcCtD
Mitoxantrone—Cough—Capecitabine—esophageal cancer	0.000182	0.00175	CcSEcCtD
Mitoxantrone—Hypertension—Capecitabine—esophageal cancer	0.00018	0.00173	CcSEcCtD
Mitoxantrone—ABCB1—lung—esophageal cancer	0.00018	0.00709	CbGeAlD
Mitoxantrone—Haemoglobin—Methotrexate—esophageal cancer	0.000179	0.00172	CcSEcCtD
Mitoxantrone—Haemorrhage—Methotrexate—esophageal cancer	0.000179	0.00171	CcSEcCtD
Mitoxantrone—Hepatitis—Methotrexate—esophageal cancer	0.000179	0.00171	CcSEcCtD
Mitoxantrone—Chest pain—Capecitabine—esophageal cancer	0.000178	0.00171	CcSEcCtD
Mitoxantrone—Arthralgia—Capecitabine—esophageal cancer	0.000178	0.00171	CcSEcCtD
Mitoxantrone—Myalgia—Capecitabine—esophageal cancer	0.000178	0.00171	CcSEcCtD
Mitoxantrone—Pharyngitis—Methotrexate—esophageal cancer	0.000177	0.0017	CcSEcCtD
Mitoxantrone—Anxiety—Capecitabine—esophageal cancer	0.000177	0.0017	CcSEcCtD
Mitoxantrone—Discomfort—Capecitabine—esophageal cancer	0.000176	0.00169	CcSEcCtD
Mitoxantrone—Confusional state—Capecitabine—esophageal cancer	0.000172	0.00165	CcSEcCtD
Mitoxantrone—Oedema—Capecitabine—esophageal cancer	0.00017	0.00164	CcSEcCtD
Mitoxantrone—Hypersensitivity—Cisplatin—esophageal cancer	0.00017	0.00164	CcSEcCtD
Mitoxantrone—Infection—Capecitabine—esophageal cancer	0.000169	0.00163	CcSEcCtD
Mitoxantrone—Shock—Capecitabine—esophageal cancer	0.000168	0.00161	CcSEcCtD
Mitoxantrone—Thrombocytopenia—Capecitabine—esophageal cancer	0.000167	0.0016	CcSEcCtD
Mitoxantrone—Tachycardia—Capecitabine—esophageal cancer	0.000166	0.0016	CcSEcCtD
Mitoxantrone—Asthenia—Cisplatin—esophageal cancer	0.000166	0.00159	CcSEcCtD
Mitoxantrone—Skin disorder—Capecitabine—esophageal cancer	0.000166	0.00159	CcSEcCtD
Mitoxantrone—Hyperhidrosis—Capecitabine—esophageal cancer	0.000165	0.00158	CcSEcCtD
Mitoxantrone—Anorexia—Capecitabine—esophageal cancer	0.000162	0.00156	CcSEcCtD
Mitoxantrone—Chills—Methotrexate—esophageal cancer	0.00016	0.00154	CcSEcCtD
Mitoxantrone—Hypotension—Capecitabine—esophageal cancer	0.000159	0.00153	CcSEcCtD
Mitoxantrone—Diarrhoea—Cisplatin—esophageal cancer	0.000158	0.00152	CcSEcCtD
Mitoxantrone—Alopecia—Methotrexate—esophageal cancer	0.000158	0.00152	CcSEcCtD
Mitoxantrone—Erythema—Methotrexate—esophageal cancer	0.000155	0.00149	CcSEcCtD
Mitoxantrone—Musculoskeletal discomfort—Capecitabine—esophageal cancer	0.000155	0.00149	CcSEcCtD
Mitoxantrone—Paraesthesia—Capecitabine—esophageal cancer	0.000153	0.00147	CcSEcCtD
Mitoxantrone—Dysgeusia—Methotrexate—esophageal cancer	0.000152	0.00146	CcSEcCtD
Mitoxantrone—Dyspnoea—Capecitabine—esophageal cancer	0.000152	0.00146	CcSEcCtD
Mitoxantrone—Back pain—Methotrexate—esophageal cancer	0.00015	0.00144	CcSEcCtD
Mitoxantrone—Dyspepsia—Capecitabine—esophageal cancer	0.00015	0.00144	CcSEcCtD
Mitoxantrone—Decreased appetite—Capecitabine—esophageal cancer	0.000148	0.00142	CcSEcCtD
Mitoxantrone—Vomiting—Cisplatin—esophageal cancer	0.000147	0.00141	CcSEcCtD
Mitoxantrone—Fatigue—Capecitabine—esophageal cancer	0.000147	0.00141	CcSEcCtD
Mitoxantrone—Vision blurred—Methotrexate—esophageal cancer	0.000147	0.00141	CcSEcCtD
Mitoxantrone—Rash—Cisplatin—esophageal cancer	0.000146	0.0014	CcSEcCtD
Mitoxantrone—Constipation—Capecitabine—esophageal cancer	0.000146	0.0014	CcSEcCtD
Mitoxantrone—Pain—Capecitabine—esophageal cancer	0.000146	0.0014	CcSEcCtD
Mitoxantrone—Dermatitis—Cisplatin—esophageal cancer	0.000146	0.0014	CcSEcCtD
Mitoxantrone—Ill-defined disorder—Methotrexate—esophageal cancer	0.000144	0.00138	CcSEcCtD
Mitoxantrone—Anaemia—Methotrexate—esophageal cancer	0.000144	0.00138	CcSEcCtD
Mitoxantrone—Feeling abnormal—Capecitabine—esophageal cancer	0.00014	0.00135	CcSEcCtD
Mitoxantrone—Malaise—Methotrexate—esophageal cancer	0.00014	0.00135	CcSEcCtD
Mitoxantrone—Gastrointestinal pain—Capecitabine—esophageal cancer	0.000139	0.00134	CcSEcCtD
Mitoxantrone—Leukopenia—Methotrexate—esophageal cancer	0.000139	0.00134	CcSEcCtD
Mitoxantrone—Nausea—Cisplatin—esophageal cancer	0.000137	0.00132	CcSEcCtD
Mitoxantrone—Cough—Methotrexate—esophageal cancer	0.000136	0.0013	CcSEcCtD
Mitoxantrone—Urticaria—Capecitabine—esophageal cancer	0.000135	0.0013	CcSEcCtD
Mitoxantrone—Abdominal pain—Capecitabine—esophageal cancer	0.000135	0.00129	CcSEcCtD
Mitoxantrone—Body temperature increased—Capecitabine—esophageal cancer	0.000135	0.00129	CcSEcCtD
Mitoxantrone—Convulsion—Methotrexate—esophageal cancer	0.000135	0.00129	CcSEcCtD
Mitoxantrone—Arthralgia—Methotrexate—esophageal cancer	0.000132	0.00127	CcSEcCtD
Mitoxantrone—Chest pain—Methotrexate—esophageal cancer	0.000132	0.00127	CcSEcCtD
Mitoxantrone—Myalgia—Methotrexate—esophageal cancer	0.000132	0.00127	CcSEcCtD
Mitoxantrone—Discomfort—Methotrexate—esophageal cancer	0.000131	0.00126	CcSEcCtD
Mitoxantrone—Confusional state—Methotrexate—esophageal cancer	0.000128	0.00123	CcSEcCtD
Mitoxantrone—Anaphylactic shock—Methotrexate—esophageal cancer	0.000127	0.00122	CcSEcCtD
Mitoxantrone—Infection—Methotrexate—esophageal cancer	0.000126	0.00121	CcSEcCtD
Mitoxantrone—Hypersensitivity—Capecitabine—esophageal cancer	0.000126	0.00121	CcSEcCtD
Mitoxantrone—Thrombocytopenia—Methotrexate—esophageal cancer	0.000124	0.00119	CcSEcCtD
Mitoxantrone—Skin disorder—Methotrexate—esophageal cancer	0.000123	0.00118	CcSEcCtD
Mitoxantrone—ABCB1—lymph node—esophageal cancer	0.000123	0.00485	CbGeAlD
Mitoxantrone—Hyperhidrosis—Methotrexate—esophageal cancer	0.000123	0.00118	CcSEcCtD
Mitoxantrone—Asthenia—Capecitabine—esophageal cancer	0.000122	0.00117	CcSEcCtD
Mitoxantrone—Anorexia—Methotrexate—esophageal cancer	0.000121	0.00116	CcSEcCtD
Mitoxantrone—Hypotension—Methotrexate—esophageal cancer	0.000119	0.00114	CcSEcCtD
Mitoxantrone—Diarrhoea—Capecitabine—esophageal cancer	0.000117	0.00112	CcSEcCtD
Mitoxantrone—Musculoskeletal discomfort—Methotrexate—esophageal cancer	0.000116	0.00111	CcSEcCtD
Mitoxantrone—Paraesthesia—Methotrexate—esophageal cancer	0.000114	0.00109	CcSEcCtD
Mitoxantrone—Dyspnoea—Methotrexate—esophageal cancer	0.000113	0.00109	CcSEcCtD
Mitoxantrone—Somnolence—Methotrexate—esophageal cancer	0.000113	0.00108	CcSEcCtD
Mitoxantrone—Dyspepsia—Methotrexate—esophageal cancer	0.000112	0.00107	CcSEcCtD
Mitoxantrone—Decreased appetite—Methotrexate—esophageal cancer	0.00011	0.00106	CcSEcCtD
Mitoxantrone—Fatigue—Methotrexate—esophageal cancer	0.000109	0.00105	CcSEcCtD
Mitoxantrone—Pain—Methotrexate—esophageal cancer	0.000108	0.00104	CcSEcCtD
Mitoxantrone—Vomiting—Capecitabine—esophageal cancer	0.000108	0.00104	CcSEcCtD
Mitoxantrone—Rash—Capecitabine—esophageal cancer	0.000107	0.00103	CcSEcCtD
Mitoxantrone—Dermatitis—Capecitabine—esophageal cancer	0.000107	0.00103	CcSEcCtD
Mitoxantrone—Headache—Capecitabine—esophageal cancer	0.000107	0.00103	CcSEcCtD
Mitoxantrone—Feeling abnormal—Methotrexate—esophageal cancer	0.000105	0.001	CcSEcCtD
Mitoxantrone—Gastrointestinal pain—Methotrexate—esophageal cancer	0.000104	0.000996	CcSEcCtD
Mitoxantrone—Nausea—Capecitabine—esophageal cancer	0.000101	0.000972	CcSEcCtD
Mitoxantrone—Urticaria—Methotrexate—esophageal cancer	0.000101	0.000968	CcSEcCtD
Mitoxantrone—Abdominal pain—Methotrexate—esophageal cancer	0.0001	0.000963	CcSEcCtD
Mitoxantrone—Body temperature increased—Methotrexate—esophageal cancer	0.0001	0.000963	CcSEcCtD
Mitoxantrone—Hypersensitivity—Methotrexate—esophageal cancer	9.35e-05	0.000898	CcSEcCtD
Mitoxantrone—Asthenia—Methotrexate—esophageal cancer	9.1e-05	0.000874	CcSEcCtD
Mitoxantrone—Diarrhoea—Methotrexate—esophageal cancer	8.68e-05	0.000834	CcSEcCtD
Mitoxantrone—Vomiting—Methotrexate—esophageal cancer	8.07e-05	0.000775	CcSEcCtD
Mitoxantrone—Rash—Methotrexate—esophageal cancer	8e-05	0.000768	CcSEcCtD
Mitoxantrone—Dermatitis—Methotrexate—esophageal cancer	7.99e-05	0.000767	CcSEcCtD
Mitoxantrone—Headache—Methotrexate—esophageal cancer	7.95e-05	0.000763	CcSEcCtD
Mitoxantrone—Nausea—Methotrexate—esophageal cancer	7.54e-05	0.000724	CcSEcCtD
Mitoxantrone—CYP1B1—Metabolism—ADH1B—esophageal cancer	2.8e-05	0.000256	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—TYMP—esophageal cancer	2.77e-05	0.000253	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—HIST1H2BM—esophageal cancer	2.76e-05	0.000252	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—GAPDH—esophageal cancer	2.76e-05	0.000252	CbGpPWpGaD
Mitoxantrone—ABCC1—Transmembrane transport of small molecules—ABCB1—esophageal cancer	2.72e-05	0.000248	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—CYP26A1—esophageal cancer	2.69e-05	0.000246	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—TYMP—esophageal cancer	2.68e-05	0.000244	CbGpPWpGaD
Mitoxantrone—CYP3A4—Biological oxidations—CYP1B1—esophageal cancer	2.65e-05	0.000242	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—ALOX15—esophageal cancer	2.62e-05	0.00024	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metapathway biotransformation—CYP1B1—esophageal cancer	2.61e-05	0.000239	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—CYP26A1—esophageal cancer	2.6e-05	0.000238	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—ADH1B—esophageal cancer	2.55e-05	0.000233	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—ALOX15—esophageal cancer	2.54e-05	0.000232	CbGpPWpGaD
Mitoxantrone—TOP2A—Cell Cycle—CDKN2A—esophageal cancer	2.5e-05	0.000229	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—GSTO1—esophageal cancer	2.5e-05	0.000229	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—TPI1—esophageal cancer	2.5e-05	0.000229	CbGpPWpGaD
Mitoxantrone—ABCG2—Transmembrane transport of small molecules—HMOX1—esophageal cancer	2.49e-05	0.000228	CbGpPWpGaD
Mitoxantrone—CYP3A4—Biological oxidations—CYP19A1—esophageal cancer	2.49e-05	0.000228	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metapathway biotransformation—CYP19A1—esophageal cancer	2.46e-05	0.000224	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—CASP8—esophageal cancer	2.46e-05	0.000224	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—SLC10A2—esophageal cancer	2.45e-05	0.000224	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—CA1—esophageal cancer	2.45e-05	0.000224	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—CREBBP—esophageal cancer	2.44e-05	0.000223	CbGpPWpGaD
Mitoxantrone—BTK—Innate Immune System—EGFR—esophageal cancer	2.44e-05	0.000223	CbGpPWpGaD
Mitoxantrone—ABCB1—Transmembrane transport of small molecules—ABCC2—esophageal cancer	2.44e-05	0.000223	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—XIAP—esophageal cancer	2.43e-05	0.000223	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—TYMP—esophageal cancer	2.43e-05	0.000222	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—TPI1—esophageal cancer	2.42e-05	0.000221	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—GSTO1—esophageal cancer	2.42e-05	0.000221	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—ALDOB—esophageal cancer	2.4e-05	0.000219	CbGpPWpGaD
Mitoxantrone—ABCG2—Transmembrane transport of small molecules—ABCB1—esophageal cancer	2.39e-05	0.000218	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—CYP26A1—esophageal cancer	2.37e-05	0.000216	CbGpPWpGaD
Mitoxantrone—TOP2A—Cell Cycle, Mitotic—CCND1—esophageal cancer	2.37e-05	0.000216	CbGpPWpGaD
Mitoxantrone—BTK—Adaptive Immune System—EGFR—esophageal cancer	2.34e-05	0.000214	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—ALDOB—esophageal cancer	2.32e-05	0.000212	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—GAPDH—esophageal cancer	2.31e-05	0.000211	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—ALOX15—esophageal cancer	2.31e-05	0.000211	CbGpPWpGaD
Mitoxantrone—TOP2A—Cell Cycle, Mitotic—CDKN1A—esophageal cancer	2.29e-05	0.000209	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—CRABP1—esophageal cancer	2.29e-05	0.000209	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—B2M—esophageal cancer	2.26e-05	0.000207	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—CA2—esophageal cancer	2.24e-05	0.000205	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—GAPDH—esophageal cancer	2.23e-05	0.000204	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—CRABP1—esophageal cancer	2.21e-05	0.000202	CbGpPWpGaD
Mitoxantrone—ABCB1—Transmembrane transport of small molecules—GNG7—esophageal cancer	2.21e-05	0.000202	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—TPI1—esophageal cancer	2.2e-05	0.000201	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—GSTO1—esophageal cancer	2.2e-05	0.000201	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—esophageal cancer	2.19e-05	0.0002	CbGpPWpGaD
Mitoxantrone—TOP2A—Cell Cycle, Mitotic—EP300—esophageal cancer	2.18e-05	0.000199	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—GNG7—esophageal cancer	2.18e-05	0.000199	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—CREBBP—esophageal cancer	2.18e-05	0.000199	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—SLC52A3—esophageal cancer	2.17e-05	0.000198	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—BLVRB—esophageal cancer	2.17e-05	0.000198	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—ENO1—esophageal cancer	2.17e-05	0.000198	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—PSME1—esophageal cancer	2.14e-05	0.000195	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—PSME2—esophageal cancer	2.14e-05	0.000195	CbGpPWpGaD
Mitoxantrone—TOP2A—Cell Cycle—CCND1—esophageal cancer	2.12e-05	0.000193	CbGpPWpGaD
Mitoxantrone—BTK—Innate Immune System—PIK3CA—esophageal cancer	2.11e-05	0.000193	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—ALDOB—esophageal cancer	2.11e-05	0.000193	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—BCL2—esophageal cancer	2.11e-05	0.000193	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—GNG7—esophageal cancer	2.1e-05	0.000192	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—PLCE1—esophageal cancer	2.09e-05	0.000191	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—ADH7—esophageal cancer	2.09e-05	0.000191	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—CALR—esophageal cancer	2.05e-05	0.000188	CbGpPWpGaD
Mitoxantrone—TOP2A—Cell Cycle—CDKN1A—esophageal cancer	2.05e-05	0.000187	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—ERBB2—esophageal cancer	2.05e-05	0.000187	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—ALDH2—esophageal cancer	2.04e-05	0.000186	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—GAPDH—esophageal cancer	2.03e-05	0.000186	CbGpPWpGaD
Mitoxantrone—BTK—Adaptive Immune System—PIK3CA—esophageal cancer	2.03e-05	0.000186	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—CRABP1—esophageal cancer	2.01e-05	0.000184	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—FBXW7—esophageal cancer	1.98e-05	0.000181	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—ALDH2—esophageal cancer	1.97e-05	0.00018	CbGpPWpGaD
Mitoxantrone—TOP2A—Cell Cycle—EP300—esophageal cancer	1.95e-05	0.000178	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—GSTT1—esophageal cancer	1.94e-05	0.000177	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—CYP2A6—esophageal cancer	1.92e-05	0.000175	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—GNG7—esophageal cancer	1.91e-05	0.000175	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	1.91e-05	0.000175	CbGpPWpGaD
Mitoxantrone—TOP2A—Cell Cycle, Mitotic—MYC—esophageal cancer	1.9e-05	0.000173	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—GSTT1—esophageal cancer	1.88e-05	0.000171	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—esophageal cancer	1.88e-05	0.000171	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—CYP2A6—esophageal cancer	1.85e-05	0.000169	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	1.85e-05	0.000169	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—CA1—esophageal cancer	1.85e-05	0.000169	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—SLC10A2—esophageal cancer	1.85e-05	0.000169	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—ADH1B—esophageal cancer	1.83e-05	0.000167	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—esophageal cancer	1.82e-05	0.000167	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—PTGS1—esophageal cancer	1.82e-05	0.000166	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—ENO1—esophageal cancer	1.82e-05	0.000166	CbGpPWpGaD
Mitoxantrone—ABCC1—Transmembrane transport of small molecules—CREBBP—esophageal cancer	1.82e-05	0.000166	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—ALDH2—esophageal cancer	1.79e-05	0.000164	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—PSME1—esophageal cancer	1.79e-05	0.000164	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—PSME2—esophageal cancer	1.79e-05	0.000164	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—esophageal cancer	1.78e-05	0.000163	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—ENO1—esophageal cancer	1.76e-05	0.000161	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—PTGS1—esophageal cancer	1.76e-05	0.000161	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—CDKN1A—esophageal cancer	1.75e-05	0.00016	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—TYMP—esophageal cancer	1.75e-05	0.00016	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—PSME2—esophageal cancer	1.73e-05	0.000158	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—PSME1—esophageal cancer	1.73e-05	0.000158	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—GSTT1—esophageal cancer	1.71e-05	0.000156	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—CYP26A1—esophageal cancer	1.7e-05	0.000155	CbGpPWpGaD
Mitoxantrone—TOP2A—Cell Cycle—MYC—esophageal cancer	1.7e-05	0.000155	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—CA2—esophageal cancer	1.69e-05	0.000154	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—CYP2A6—esophageal cancer	1.69e-05	0.000154	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—EP300—esophageal cancer	1.66e-05	0.000152	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—ALOX15—esophageal cancer	1.66e-05	0.000151	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—esophageal cancer	1.61e-05	0.000147	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—TGFBR2—esophageal cancer	1.61e-05	0.000147	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—ENO1—esophageal cancer	1.6e-05	0.000146	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—PTGS1—esophageal cancer	1.6e-05	0.000146	CbGpPWpGaD
Mitoxantrone—ABCG2—Transmembrane transport of small molecules—CREBBP—esophageal cancer	1.6e-05	0.000146	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—TPI1—esophageal cancer	1.58e-05	0.000144	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—GSTO1—esophageal cancer	1.58e-05	0.000144	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—PSME2—esophageal cancer	1.58e-05	0.000144	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—PSME1—esophageal cancer	1.58e-05	0.000144	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—ADH7—esophageal cancer	1.57e-05	0.000144	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—PLCE1—esophageal cancer	1.57e-05	0.000144	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	1.56e-05	0.000143	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—esophageal cancer	1.56e-05	0.000142	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—CYP1B1—esophageal cancer	1.55e-05	0.000141	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—SMAD4—esophageal cancer	1.52e-05	0.000139	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—ALDOB—esophageal cancer	1.52e-05	0.000138	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	1.51e-05	0.000138	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—esophageal cancer	1.48e-05	0.000135	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—GAPDH—esophageal cancer	1.46e-05	0.000133	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—CYP19A1—esophageal cancer	1.45e-05	0.000133	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—CRABP1—esophageal cancer	1.45e-05	0.000132	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—EGFR—esophageal cancer	1.42e-05	0.00013	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—CYP19A1—esophageal cancer	1.41e-05	0.000128	CbGpPWpGaD
Mitoxantrone—TOP2A—Cell Cycle—TP53—esophageal cancer	1.39e-05	0.000127	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—ADH1B—esophageal cancer	1.38e-05	0.000126	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—GNG7—esophageal cancer	1.37e-05	0.000126	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—CYP1B1—esophageal cancer	1.36e-05	0.000124	CbGpPWpGaD
Mitoxantrone—ABCB1—Transmembrane transport of small molecules—HMOX1—esophageal cancer	1.35e-05	0.000123	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—SLC52A3—esophageal cancer	1.34e-05	0.000122	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—BLVRB—esophageal cancer	1.34e-05	0.000122	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—HMOX1—esophageal cancer	1.33e-05	0.000121	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—TYMP—esophageal cancer	1.32e-05	0.00012	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	1.3e-05	0.000119	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—esophageal cancer	1.29e-05	0.000118	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—ALDH2—esophageal cancer	1.29e-05	0.000118	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—HMOX1—esophageal cancer	1.28e-05	0.000117	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—CYP26A1—esophageal cancer	1.28e-05	0.000117	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—CYP19A1—esophageal cancer	1.28e-05	0.000117	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—ABCB1—esophageal cancer	1.27e-05	0.000116	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—esophageal cancer	1.26e-05	0.000115	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	1.26e-05	0.000115	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—ALOX15—esophageal cancer	1.25e-05	0.000114	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—HIF1A—esophageal cancer	1.24e-05	0.000114	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—PIK3CA—esophageal cancer	1.23e-05	0.000113	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—ABCB1—esophageal cancer	1.23e-05	0.000112	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—GSTT1—esophageal cancer	1.23e-05	0.000112	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—CYP2A6—esophageal cancer	1.21e-05	0.000111	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—GSTO1—esophageal cancer	1.19e-05	0.000109	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—TPI1—esophageal cancer	1.19e-05	0.000109	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—HMOX1—esophageal cancer	1.17e-05	0.000107	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—ENO1—esophageal cancer	1.15e-05	0.000105	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—PTGS1—esophageal cancer	1.15e-05	0.000105	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—ALDOB—esophageal cancer	1.14e-05	0.000104	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—CA1—esophageal cancer	1.14e-05	0.000104	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—SLC10A2—esophageal cancer	1.14e-05	0.000104	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—PSME1—esophageal cancer	1.13e-05	0.000103	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—PSME2—esophageal cancer	1.13e-05	0.000103	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—NOS2—esophageal cancer	1.13e-05	0.000103	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—NOTCH1—esophageal cancer	1.12e-05	0.000102	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—ABCB1—esophageal cancer	1.12e-05	0.000102	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—GAPDH—esophageal cancer	1.1e-05	0.0001	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—esophageal cancer	1.1e-05	0.0001	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—CRABP1—esophageal cancer	1.09e-05	9.95e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—esophageal cancer	1.06e-05	9.69e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—CA2—esophageal cancer	1.04e-05	9.51e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—GNG7—esophageal cancer	1.04e-05	9.46e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—CREBBP—esophageal cancer	1.02e-05	9.28e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—CYP1B1—esophageal cancer	9.76e-06	8.92e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—ALDH2—esophageal cancer	9.7e-06	8.87e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—PLCE1—esophageal cancer	9.67e-06	8.84e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—ADH7—esophageal cancer	9.67e-06	8.84e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	9.62e-06	8.79e-05	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	9.31e-06	8.5e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—GSTT1—esophageal cancer	9.23e-06	8.43e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—CYP19A1—esophageal cancer	9.18e-06	8.39e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—CYP2A6—esophageal cancer	9.12e-06	8.34e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—NOS3—esophageal cancer	9.09e-06	8.31e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—ENO1—esophageal cancer	8.65e-06	7.9e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—PTGS1—esophageal cancer	8.65e-06	7.9e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Transmembrane transport of small molecules—CREBBP—esophageal cancer	8.64e-06	7.9e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—PSME2—esophageal cancer	8.52e-06	7.79e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—PSME1—esophageal cancer	8.52e-06	7.79e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—CREBBP—esophageal cancer	8.51e-06	7.77e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—ERBB2—esophageal cancer	8.51e-06	7.77e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—ADH1B—esophageal cancer	8.48e-06	7.75e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—HMOX1—esophageal cancer	8.38e-06	7.65e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—PTGS2—esophageal cancer	8.32e-06	7.6e-05	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—CREBBP—esophageal cancer	8.23e-06	7.52e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—TYMP—esophageal cancer	8.11e-06	7.41e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—ABCB1—esophageal cancer	8.04e-06	7.35e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—CYP26A1—esophageal cancer	7.89e-06	7.21e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—ALOX15—esophageal cancer	7.69e-06	7.02e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—NOS3—esophageal cancer	7.61e-06	6.96e-05	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—CREBBP—esophageal cancer	7.48e-06	6.84e-05	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—NOS3—esophageal cancer	7.37e-06	6.73e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—CYP1B1—esophageal cancer	7.35e-06	6.72e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—GSTO1—esophageal cancer	7.33e-06	6.7e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—TPI1—esophageal cancer	7.33e-06	6.7e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—CDKN1A—esophageal cancer	7.27e-06	6.64e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—ALDOB—esophageal cancer	7.03e-06	6.42e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—PTGS2—esophageal cancer	6.96e-06	6.36e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—EP300—esophageal cancer	6.92e-06	6.32e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—CYP19A1—esophageal cancer	6.91e-06	6.32e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—GAPDH—esophageal cancer	6.77e-06	6.18e-05	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—PTGS2—esophageal cancer	6.74e-06	6.16e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—CRABP1—esophageal cancer	6.71e-06	6.13e-05	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—NOS3—esophageal cancer	6.7e-06	6.12e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—GNG7—esophageal cancer	6.38e-06	5.83e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—HMOX1—esophageal cancer	6.31e-06	5.76e-05	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—PTGS2—esophageal cancer	6.13e-06	5.6e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—MYC—esophageal cancer	6.03e-06	5.51e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—ALDH2—esophageal cancer	5.98e-06	5.46e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—EGFR—esophageal cancer	5.9e-06	5.39e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—EP300—esophageal cancer	5.79e-06	5.29e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—GSTT1—esophageal cancer	5.68e-06	5.2e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—CYP2A6—esophageal cancer	5.62e-06	5.14e-05	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—EP300—esophageal cancer	5.6e-06	5.12e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—CREBBP—esophageal cancer	5.37e-06	4.91e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—PTGS1—esophageal cancer	5.33e-06	4.87e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—ENO1—esophageal cancer	5.33e-06	4.87e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—PSME1—esophageal cancer	5.25e-06	4.8e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—PSME2—esophageal cancer	5.25e-06	4.8e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—PIK3CA—esophageal cancer	5.12e-06	4.68e-05	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—EP300—esophageal cancer	5.1e-06	4.66e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—NOS3—esophageal cancer	4.81e-06	4.4e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—CYP1B1—esophageal cancer	4.53e-06	4.14e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—PTGS2—esophageal cancer	4.4e-06	4.02e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—PIK3CA—esophageal cancer	4.28e-06	3.92e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—CYP19A1—esophageal cancer	4.26e-06	3.89e-05	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—PIK3CA—esophageal cancer	4.14e-06	3.79e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—CREBBP—esophageal cancer	4.05e-06	3.7e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—HMOX1—esophageal cancer	3.89e-06	3.55e-05	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—PIK3CA—esophageal cancer	3.77e-06	3.45e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—ABCB1—esophageal cancer	3.73e-06	3.41e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—EP300—esophageal cancer	3.66e-06	3.34e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—NOS3—esophageal cancer	3.62e-06	3.31e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—PTGS2—esophageal cancer	3.31e-06	3.03e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—EP300—esophageal cancer	2.76e-06	2.52e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—PIK3CA—esophageal cancer	2.71e-06	2.47e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—CREBBP—esophageal cancer	2.49e-06	2.28e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—NOS3—esophageal cancer	2.23e-06	2.04e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—PTGS2—esophageal cancer	2.04e-06	1.87e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—PIK3CA—esophageal cancer	2.04e-06	1.86e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—EP300—esophageal cancer	1.7e-06	1.55e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—PIK3CA—esophageal cancer	1.26e-06	1.15e-05	CbGpPWpGaD
